Xuezhen Luo
7PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 14, 2022
RNA-seq and ATAC-seq analysis of CD163+ macrophage-induced progestin-insensitive endometrial cancer cells.Lulu Wang, Qiaoying Lv, Pengfei Wu
|Mar 05, 2022
Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients.Pengfei Wu, Qiaoying Lv, Jun Guan
|Sep 27, 2021
Efficacy of sentinel lymph node mapping in endometrial cancer with low- or high-intermediate risk.Yu Xue, Wei-Wei Shan, Qian Wang
|Sep 08, 2021
The efficiency of a combined injection technique for sentinel lymph node mapping in intermediate-high-risk endometrial cancer.Qian Wang, Bo Wang, Lulu Wang
|Jun 16, 2021
Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome.Lulu Wang, Xuezhen Luo, Qian Wang
|Nov 28, 2018
The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.Jun Guan, Liying Xie, Xuezhen Luo
Pageof 2
